Factory Supply QSC Tirzepatide Powder | 99% Purity Pharmaceutical Grade

QSC Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound demonstrates significantly enhanced efficacy in glucose regulation and weight management compared to selective GLP-1 receptor agonists.

The molecular structure of QSC tirzepatide enables superior binding affinity to both GIP and GLP-1 receptors, with particular preference for GIP receptors. This unique pharmacological profile results in more effective reduction of hyperglycemia in research models. Our QSC tirzepatide is synthesized under strict quality control measures to ensure consistent high purity and biological activity.

As a research chemical, QSC tirzepatide offers scientists a valuable tool for investigating metabolic disorders and developing new therapeutic approaches. The compound has shown promising results in preclinical studies for its ability to mimic natural GIP activity while simultaneously activating GLP-1 pathways.

Our manufacturing facility produces QSC tirzepatide under cGMP-like conditions to ensure batch-to-batch consistency. Each lot undergoes rigorous analytical testing including HPLC purity verification and mass spectrometry confirmation. We offer flexible packaging options to meet various research requirements.